Dynamic subunit stoichiometry confers a progressive continuum of pharmacological sensitivity by KCNQ potassium channels
Open Access
- 6 May 2013
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 110 (21), 8732-8737
- https://doi.org/10.1073/pnas.1300684110
Abstract
Voltage-gated KCNQ1 (Kv7.1) potassium channels are expressed abundantly in heart but they are also found in multiple other tissues. Differential coassembly with single transmembrane KCNE beta subunits in different cell types gives rise to a variety of biophysical properties, hence endowing distinct physiological roles for KCNQ1–KCNEx complexes. Mutations in either KCNQ1 or KCNE1 genes result in diseases in brain, heart, and the respiratory system. In addition to complexities arising from existence of five KCNE subunits, KCNE1 to KCNE5, recent studies in heterologous systems suggest unorthodox stoichiometric dynamics in subunit assembly is dependent on KCNE expression levels. The resultant KCNQ1–KCNE channel complexes may have a range of zero to two or even up to four KCNE subunits coassembling per KCNQ1 tetramer. These findings underscore the need to assess the selectivity of small-molecule KCNQ1 modulators on these different assemblies. Here we report a unique small-molecule gating modulator, ML277, that potentiates both homomultimeric KCNQ1 channels and unsaturated heteromultimeric (KCNQ1)4(KCNE1)n (n < 4) channels. Progressive increase of KCNE1 or KCNE3 expression reduces efficacy of ML277 and eventually abolishes ML277-mediated augmentation. In cardiomyocytes, the slowly activating delayed rectifier potassium current, or IKs, is believed to be a heteromultimeric combination of KCNQ1 and KCNE1, but it is not entirely clear whether IKs is mediated by KCNE-saturated KCNQ1 channels or by channels with intermediate stoichiometries. We found ML277 effectively augments IKs current of cultured human cardiomyocytes and shortens action potential duration. These data indicate that unsaturated heteromultimeric (KCNQ1)4(KCNE1)n channels are present as components of IKs and are pharmacologically distinct from KCNE-saturated KCNQ1–KCNE1 channels.Keywords
This publication has 44 references indexed in Scilit:
- Hexachlorophene Is a Potent KCNQ1/KCNE1 Potassium Channel Activator Which Rescues LQTs MutantsPLOS ONE, 2012
- Identification of (R)-N-(4-(4-methoxyphenyl)thiazol-2-yl)-1-tosylpiperidine-2-carboxamide, ML277, as a novel, potent and selective Kv7.1 (KCNQ1) potassium channel activatorBioorganic & Medicinal Chemistry Letters, 2012
- Modulation of hERG potassium channel gating normalizes action potential duration prolonged by dysfunctional KCNQ1 potassium channelProceedings of the National Academy of Sciences of the United States of America, 2012
- Stoichiometry of the Slow Iks Potassium Channel in Human Embryonic Stem Cell-Derived MyocytesPediatric Cardiology, 2012
- Characterization of KCNQ1 atrial fibrillation mutations reveals distinct dependence on KCNE1The Journal of general physiology, 2012
- The mechanism of action of retigabine (ezogabine), a first‐in‐class K+ channel opener for the treatment of epilepsyEpilepsia, 2012
- Driving With No Brakes: Molecular Pathophysiology of Kv7 Potassium ChannelsPhysiology, 2011
- The cardiac I Ks channel, complex indeedProceedings of the National Academy of Sciences of the United States of America, 2010
- British Journal of Pharmacology, 2001
- Retigabine, A Novel Anti-Convulsant, Enhances Activation of KCNQ2/Q3 Potassium ChannelsMolecular Pharmacology, 2000